A Study of YL242 in Subjects With Advanced Solid Tumors

Clinical trial NCT07197827 · RECRUITING

Trial details

NCT number: NCT07197827
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-09-22
Primary completion: 2028-09-01
Enrollment: 424

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.